U
KYTH

UBS’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

UBS’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3K Hold
100
– – ﹤0.01% 9903
2014
Q2 		$4K Sell
100
-220
-69% -$7.68K ﹤0.01% 9762
2014
Q1 		$13K Sell
320
-675
-68% -$30.2K ﹤0.01% 8648
2013
Q4 		$38K Buy
995
+745
+298% +$30.9K ﹤0.01% 7337
2013
Q3 		$11K Hold
250
– – ﹤0.01% 8768
2013
Q2 		$7K Buy
+250
New +$5.72K ﹤0.01% 9059

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

UBS's KYTH Position: Q3 2014 in Review

UBS held its KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) position steady in Q3 2014 at 100 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #9903.

UBS first reported a position in KYTH in Q2 2013 and has held it in 6 quarters since. The position peaked at $38K in Q4 2013. 110 funds tracked by Wall St. Rank hold KYTH as of Q3 2014.

  • UBS held 100 shares of KYTHERA BIOPHARMACEUTICALS, INC COM worth $3K as of Q3 2014.
  • UBS left its KYTHERA BIOPHARMACEUTICALS, INC COM share count unchanged in Q3 2014.
  • KYTHERA BIOPHARMACEUTICALS, INC COM made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9903 holding.
  • UBS first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and has held it in 6 quarters since.
  • UBS's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $38K in Q4 2013.
  • 110 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.